Viking Therapeutics Inc (VKTX)
74.31
+5.45
(+7.91%)
USD |
NASDAQ |
Apr 26, 16:00
74.69
+0.38
(+0.51%)
After-Hours: 20:00
Viking Therapeutics Price to Book Value: 8.774 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 8.774 |
| April 25, 2024 | 8.131 |
| April 24, 2024 | 7.683 |
| April 23, 2024 | 7.666 |
| April 22, 2024 | 7.539 |
| April 19, 2024 | 7.488 |
| April 18, 2024 | 7.636 |
| April 17, 2024 | 7.848 |
| April 16, 2024 | 8.023 |
| April 15, 2024 | 7.905 |
| April 12, 2024 | 8.099 |
| April 11, 2024 | 8.365 |
| April 10, 2024 | 8.457 |
| April 09, 2024 | 8.596 |
| April 08, 2024 | 8.956 |
| April 05, 2024 | 9.024 |
| April 04, 2024 | 8.697 |
| April 03, 2024 | 9.258 |
| April 02, 2024 | 9.130 |
| April 01, 2024 | 9.384 |
| March 28, 2024 | 25.94 |
| March 27, 2024 | 26.33 |
| March 26, 2024 | 25.54 |
| March 25, 2024 | 21.86 |
| March 22, 2024 | 21.97 |
| Date | Value |
|---|---|
| March 21, 2024 | 22.30 |
| March 20, 2024 | 22.44 |
| March 19, 2024 | 20.59 |
| March 18, 2024 | 20.01 |
| March 15, 2024 | 19.76 |
| March 14, 2024 | 20.42 |
| March 13, 2024 | 22.59 |
| March 12, 2024 | 21.06 |
| March 11, 2024 | 19.91 |
| March 08, 2024 | 22.53 |
| March 07, 2024 | 23.23 |
| March 06, 2024 | 28.62 |
| March 05, 2024 | 27.59 |
| March 04, 2024 | 28.67 |
| March 01, 2024 | 24.93 |
| February 29, 2024 | 22.54 |
| February 28, 2024 | 27.64 |
| February 27, 2024 | 24.88 |
| February 26, 2024 | 11.10 |
| February 23, 2024 | 10.79 |
| February 22, 2024 | 10.28 |
| February 21, 2024 | 10.15 |
| February 20, 2024 | 10.31 |
| February 16, 2024 | 10.44 |
| February 15, 2024 | 9.186 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8957
Minimum
Jun 16 2022
28.67
Maximum
Mar 04 2024
3.523
Average
2.002
Median
May 17 2021
Price to Book Value Benchmarks
| Eli Lilly and Co | 64.74 |
| Pfizer Inc | 1.611 |
| Madrigal Pharmaceuticals Inc | 9.490 |
| Akero Therapeutics Inc | 2.542 |
| Terns Pharmaceuticals Inc | 1.243 |
Price to Book Value Related Metrics
| Price | 74.31 |
| Earnings Yield | -1.25% |
| Market Cap | 8.194B |